SlideShare a Scribd company logo
1 of 50
Making Heart Attack
Making Heart Attack
History©
Sheldon Adelson SHAPE Trial
Proposal
The Association for Eradication of Heart Attack (www.AEHA.org)The Association for Eradication of Heart Attack (www.AEHA.org)
Quantum Leap in Preventive Cardiology
Goal
Compare SHAPE v.s. Status Quo in
Reducing Cardiovascular Mortality and
Morbidity
The Sheldon Adelson SHAPE Trial
Study Design
Randomized trial with three arms:
- SHAPE Guidelines
- NCEP Guidelines
- Traditional practice (stress testing)
Screen and treat asymptomatic at-risk
population (men 45-75y women 55-75y)
according to each of the above.
The Sheldon Adelson SHAPE Trial
Study Design
Sample size:
15,000 total
5,000 in each arm matched with age,
sex, and ethnicity
Follow up: 10 years
The Sheldon Adelson SHAPE Trial
• 15,000 persons followed for 10 years (6 clinic visits at $250 per visit,
plus $500 per patient for enrollment)
$30M
• Operations for 20 study sites at
$200K/year = $40M
The Sheldon Adelson SHAPE Trial
Goals
A) Establish AEHA (Association for the Eradication of
Heart Attack) as the global leader of a revolutionary
movement in the field of cardiology and public health
(beyond AHA and ACC) to lead the way for
eradicating heart attack.
B) Establish AVPRI (Adelson Vulnerable Patient
Research Institute) as the leading R&D institution in
developing new technologies and methods for
screening, detection, and treatment of the vulnerable
patient.
Outline of the Projects
A) AEHA:
• Public education and fundraising (SHAPE, SHAPE-a-
thon, and the Vaccine Initiative)
• Professional: ACPC (American College of Preventive
Cardiology), JPC (Journal of Preventive Cardiology), National
Guidelines and Task Forces (SHAPE, PolyPill, Vaccine),
B) AVPRI:
• Biomarker (serum markers and non-imaging monitoring tools)
• Imaging (non-contrast CT, VP Score, contrast enhanced plaque
characterization, and Molecular Imaging of )
• Immune modulation therapy (for rapid plaque stabilization)
Budget
• The proposal is based on a 50 million
dollar budget over 10 years (Phase I to
Phase V).
• Sources of funds: The Adelson Foundation
and matching funds from NIH, NSF, CV
industry, and other donors including public
fundraising.
• The Adelson Foundation will be named as
the first principal donor of AEHA, and the
sole name on AVPRI.
Budget
• The first 2 years --Phase I: including
discovery, organization, and one year
funded research for 3 institutions in
collaboration with AVPRI-- is budgeted at
$5 millions.
• During the Phase I, necessary data for
submitting NIH grants and obtaining
matching funds
• Given successful meeting of the Phase I
milestones at 18 months, a detailed budget
for Phase II-V will be submitted.
Budget for Phase I
• AVPRI 3 millions ?
– New CCS score
– Molecular Imaging?
• AEHA 2 millions ?
– SHAPE and Vaccine Task Force, Symposia,
Public Relations, Fundraising and SHAPE-a-
thon
– ACPC, and JPC Journal?
Budget for Phase I
• AVPRI 3 millions ?
– New CCS score
– Molecular Imaging?
Setting
A) AEHA and AVPRI completely non-profit and
educational. Both will be tied from organizational stand
point (board of directors etc). Fundraising foundation
arms will be the major organs of the organization and
donations will be the major source of income beside
conventions and educational products. Depending on
the success in fundraising both may offer grant
opportunities and in case of new inventions and
discoveries the organization will license out
technologies. In the far future depending on the level of
success it may open a venture arm to fund spin off start
ups that are totally focused on the mission of
eradicating heart attacks. Existing (but far less than
perfect) models for AEHA are ACS, AHA, and ADA,
and for ACPC are ACC and RSNA
Setting
B) AVPRI can be a for-profit research institute (if Adelson
wants his money back upon the success of the
institute) or a non-profit research institute. To succeed
quickly given the extremely competitive environment,
small budget, and so many other reasons, it needs to
be (or at least start) more like a virtual campus, building
projects predominantly based on collaborative multi-
center projects through various master agreements for
affiliation. It can act like a vehicle (an off shore
company) but strong management and great ideas. It
can license in technologies to complete its package
and it will be heavily involved in spinning off
technologies and incubating startups.
Heart attack is NOT
the world’s number
one problem,
extreme poverty
is.
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
“50,000 per day die of
infectious diseases which
could almost all be cured or
prevented at a cost which
is sometimes no more than
$1 per person”
World Health Organization
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
Extreme Poverty Is a Shame to the World
Much Kudus to Bono and the One Campaign
Extreme Poverty Is a Shame to the World
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
After extreme poverty and
associated infectious diseases,
eradication of heart attack
can be the most rewarding
opportunity in the 21st
century
for saving productive life years
worldwide.
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
How the World Dies Today?
YLLs: Yearsof LifeLost
Atherosclerotic
Diseases
The AEHA 2005 VP SummitThe AEHA 2005 VP SummitWorld Health Organization
Worldwide Causes of Death Source: WHO
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
> 15 Million Heart Attacks Each Year
Source:
World
Heart
Federation
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
0
5
10
15
20
25
30
1990 2020
MillionsofDeaths
fromCardiovascularCauses
Western countries
Non-Western (developing)
countries
5 million
DEATHS FROM CARDIOVASCULAR CAUSES
WORLDWIDE
KS Reddy. NEJM 2004; 350:2438
9 million
19 million
6 million
Over 2/3
of the
global
burden of
heart
attack
and
stroke is
on poor
countries.
~15m today
>25m tomorrow
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
More thanMore than
half causedhalf caused
by a suddenby a sudden
heart attackheart attack
inin healthy-healthy-
lookinglooking
populationpopulation
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
Epidemic
of Heart
Failure
Global Epidemic of Diabetes
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
Epidemic of Obesity & Diabetes in the
U.S.
1990/19911990/1991 20002000
ejt 0901–120
Mokdad et al., JAMAMokdad et al., JAMA
286:1195–1200, 2001286:1195–1200, 2001 No DataNo Data < 4%< 4% 4%-6%4%-6% > 6%> 6%
No DataNo Data < 10%< 10% 10%-14%10%-14% 15%-19%15%-19% ≥≥ 20%20%
ObesityObesity
DiabetesDiabetes
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
Global Atherosclerosis;
A Bigger Threat than
Global Warming!
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
•Heart attack is not equal
to heart disease, and is
not equal to
atherosclerosis either.
It is the attack part of
coronary heart disease
that is most devastating,
and the first focal point of
the AEHA movement.
Heart attack is the tip of
atherosclerosis problem.
The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
Prevent Attack!
Atherosclerosis Test
Negative Positive
No Risk Factors + Risk Factors
Step 1
Test for
Presence of the
Disease
Step 2
Stratify based on the
Severity of the Disease and
Presence of Risk Factors
Step 3
Treat based on
the Level of
Risk
Lower
Risk
Moderate
Risk
Moderately
High Risk
High
Risk
Very
High Risk
Apparently Healthy At-Risk Population
The 1st S.H.A.P.E. Guideline
Towards the National Screening for Heart Attack Prevention and Education (SHAPE) Program
Conceptual Flow Chart
<75th
Percentile
75th-90th
Percentile
≥90th
Percentile
Atherosclerosis Test
Very Low Risk
3
Negative Test
• CCS =0
• CIMT<50th
percentile
Lower
Risk
Moderate
Risk
Positive Test
• CCS ≥1
• CIMT ≥50th
percentile or Carotid Plaque
Moderately
High Risk
High
Risk
Very
High Risk
No Risk Factors5 + Risk Factors • CCS <100 & <75th%
• CIMT <1mm & <75th%
& No Carotid Plaque
• Coronary Calcium Score (CCS)
or
• Carotid IMT (CIMT) & Carotid Plaque4
• CCS 100-399 or >75th%
• CIMT ≥1mm or >75th%
or <50% Stenotic Plaque
• CCS >100 & >90th%
or CCS ≥400
• ≥50% Stenotic Plaque6
IndividualizedIndividualizedIndividualized5-10 years5-10 yearsRe-test Interval
<70 mg/dl<100 mg/dl
<70 Optional
<130 mg/dl
<100 Optional
<130 mg/dl<160 mg/dlLDL
Target
All >75y receive unconditional treatment2
Apparently Healthy Population Men>45y Women>55y1
ExitExit
Myocardial
IschemiaTest
NoAngiography
Follow Existing
Guidelines
Yes
The 1st S.H.A.P.E. Guideline
Towards the National Screening for Heart Attack Prevention and Education (SHAPE) Program
Step 1
Step 2
Step 3
Optional
CRP>4mg
ABI<0.9
Heart Attack Eradication History Makers
Faculty of the Past 9 VP Symposia and the SHAPE Task Force
Lets Hope the World Will Do First Thing First!
SHAPE
Get in SHAPE!

More Related Content

Similar to Ppt for adelson sketch

Why should we measure endothelial function
Why should we measure endothelial functionWhy should we measure endothelial function
Why should we measure endothelial functionEndothelix
 
7th Middle East Cardiovascular Disease and Intervention Conference
7th Middle East Cardiovascular Disease and Intervention Conference7th Middle East Cardiovascular Disease and Intervention Conference
7th Middle East Cardiovascular Disease and Intervention ConferenceCheryl Prior
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Clifford Thornton
 
Review of the New ACC/AHA Cholesterol Guidelines
Review of the New ACC/AHA Cholesterol GuidelinesReview of the New ACC/AHA Cholesterol Guidelines
Review of the New ACC/AHA Cholesterol GuidelinesTerry Shaneyfelt
 
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...CTSI at UCSF
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsTRAIN Central Station
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsTRAIN Central Station
 
Cenegenics Heart Disease Brochure
Cenegenics Heart Disease BrochureCenegenics Heart Disease Brochure
Cenegenics Heart Disease BrochureDyriRattlingourd
 
Rvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedRvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedStanford University
 
Healthcare Risk Management Plan
Healthcare Risk Management PlanHealthcare Risk Management Plan
Healthcare Risk Management PlanNashwa Elsayed
 
Stroke prevention services - quality & safety indicators
Stroke prevention services - quality & safety indicatorsStroke prevention services - quality & safety indicators
Stroke prevention services - quality & safety indicatorsHelicon Health
 
Harris Nesbiti Focus on Healthcare Conference Presentation
Harris Nesbiti Focus on Healthcare Conference PresentationHarris Nesbiti Focus on Healthcare Conference Presentation
Harris Nesbiti Focus on Healthcare Conference PresentationAdvanced Cell Technology, Inc.
 
Wearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac RehabilitationWearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac RehabilitationAshot Melik-Martirosian
 
AzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and ApprovalAzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and ApprovalAnitaBell
 
Heart Safe Community ECCU 2006
Heart Safe Community ECCU 2006Heart Safe Community ECCU 2006
Heart Safe Community ECCU 2006David Hiltz
 
2012 web presentation proposal-feb 2
2012 web presentation proposal-feb 22012 web presentation proposal-feb 2
2012 web presentation proposal-feb 2MillenniumHCS
 

Similar to Ppt for adelson sketch (20)

Why should we measure endothelial function
Why should we measure endothelial functionWhy should we measure endothelial function
Why should we measure endothelial function
 
7th Middle East Cardiovascular Disease and Intervention Conference
7th Middle East Cardiovascular Disease and Intervention Conference7th Middle East Cardiovascular Disease and Intervention Conference
7th Middle East Cardiovascular Disease and Intervention Conference
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
 
Aeha cea- shaw
Aeha   cea- shawAeha   cea- shaw
Aeha cea- shaw
 
Review of the New ACC/AHA Cholesterol Guidelines
Review of the New ACC/AHA Cholesterol GuidelinesReview of the New ACC/AHA Cholesterol Guidelines
Review of the New ACC/AHA Cholesterol Guidelines
 
Shape aha 2005
Shape   aha 2005Shape   aha 2005
Shape aha 2005
 
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
Coronary Calcium and other CVD Risk Biomarkers: From Epidemiology to Comparat...
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
 
BIO 2010 Partnering with Patients
BIO 2010 Partnering with PatientsBIO 2010 Partnering with Patients
BIO 2010 Partnering with Patients
 
Cenegenics Heart Disease Brochure
Cenegenics Heart Disease BrochureCenegenics Heart Disease Brochure
Cenegenics Heart Disease Brochure
 
Rvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons LearnedRvex Engr245 2021 Lessons Learned
Rvex Engr245 2021 Lessons Learned
 
Shape symposium slide presentation
Shape symposium slide presentationShape symposium slide presentation
Shape symposium slide presentation
 
Healthcare Risk Management Plan
Healthcare Risk Management PlanHealthcare Risk Management Plan
Healthcare Risk Management Plan
 
Stroke prevention services - quality & safety indicators
Stroke prevention services - quality & safety indicatorsStroke prevention services - quality & safety indicators
Stroke prevention services - quality & safety indicators
 
Harris Nesbiti Focus on Healthcare Conference Presentation
Harris Nesbiti Focus on Healthcare Conference PresentationHarris Nesbiti Focus on Healthcare Conference Presentation
Harris Nesbiti Focus on Healthcare Conference Presentation
 
2012 MHCC Web Presentation Proposal-Feb 2
2012 MHCC Web Presentation Proposal-Feb 22012 MHCC Web Presentation Proposal-Feb 2
2012 MHCC Web Presentation Proposal-Feb 2
 
Wearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac RehabilitationWearable Sensors for Cardiac Rehabilitation
Wearable Sensors for Cardiac Rehabilitation
 
AzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and ApprovalAzCI presents: Specialty Programs in FDA Review and Approval
AzCI presents: Specialty Programs in FDA Review and Approval
 
Heart Safe Community ECCU 2006
Heart Safe Community ECCU 2006Heart Safe Community ECCU 2006
Heart Safe Community ECCU 2006
 
2012 web presentation proposal-feb 2
2012 web presentation proposal-feb 22012 web presentation proposal-feb 2
2012 web presentation proposal-feb 2
 

More from Society for Heart Attack Prevention and Eradication

More from Society for Heart Attack Prevention and Eradication (20)

AHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner PresentationAHA SHAPE Symposium 2017 Dr. Kloner Presentation
AHA SHAPE Symposium 2017 Dr. Kloner Presentation
 
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland PresentationAHA SHAPE Symposium 2017 Dr. Greenland Presentation
AHA SHAPE Symposium 2017 Dr. Greenland Presentation
 
AHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen PresentationAHA SHAPE Symposium 2017 Dr. Yen Presentation
AHA SHAPE Symposium 2017 Dr. Yen Presentation
 
Vu lplaque1 pasterkamp
Vu lplaque1 pasterkampVu lplaque1 pasterkamp
Vu lplaque1 pasterkamp
 
Vulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patientVulnerable plaque vulnerable patient
Vulnerable plaque vulnerable patient
 
Vulnerable plaque overview
Vulnerable plaque overviewVulnerable plaque overview
Vulnerable plaque overview
 
Vulnerable patient talk in poland
Vulnerable patient talk in polandVulnerable patient talk in poland
Vulnerable patient talk in poland
 
Vulnerable patient slides without movies
Vulnerable patient slides without moviesVulnerable patient slides without movies
Vulnerable patient slides without movies
 
Vulnerable patient mar 04
Vulnerable patient mar 04Vulnerable patient mar 04
Vulnerable patient mar 04
 
Vulnerable (thrombogenic blood
Vulnerable (thrombogenic bloodVulnerable (thrombogenic blood
Vulnerable (thrombogenic blood
 
Vuln shape aha 2005
Vuln shape aha 2005Vuln shape aha 2005
Vuln shape aha 2005
 
Vuln plaque poster burke
Vuln plaque poster burkeVuln plaque poster burke
Vuln plaque poster burke
 
Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-Vp watch editorial_slide 25short-
Vp watch editorial_slide 25short-
 
Vp watch editorial_slide25
Vp watch editorial_slide25Vp watch editorial_slide25
Vp watch editorial_slide25
 
Vp watch editorial_slide25short-
Vp watch editorial_slide25short-Vp watch editorial_slide25short-
Vp watch editorial_slide25short-
 
Vp watch2002
Vp watch2002Vp watch2002
Vp watch2002
 
Vp symposium31602
Vp symposium31602Vp symposium31602
Vp symposium31602
 
Vpschoenhagen
VpschoenhagenVpschoenhagen
Vpschoenhagen
 
Vp meeting orlando2003_new template
Vp meeting orlando2003_new templateVp meeting orlando2003_new template
Vp meeting orlando2003_new template
 
Vpiii lobby-02
Vpiii lobby-02Vpiii lobby-02
Vpiii lobby-02
 

Recently uploaded

Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknownarwatsonia7
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...narwatsonia7
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknownarwatsonia7
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceNehru place Escorts
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingNehru place Escorts
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersnarwatsonia7
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...narwatsonia7
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 

Recently uploaded (20)

Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
 
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service LucknowCall Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
Call Girl Lucknow Mallika 7001305949 Independent Escort Service Lucknow
 
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
Call Girls Service in Bommanahalli - 7001305949 with real photos and phone nu...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
 
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service MumbaiVIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
VIP Call Girls Mumbai Arpita 9910780858 Independent Escort Service Mumbai
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbersBook Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
Book Call Girls in Kasavanahalli - 7001305949 with real photos and phone numbers
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
Call Girls Frazer Town Just Call 7001305949 Top Class Call Girl Service Avail...
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 

Ppt for adelson sketch

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Making Heart Attack Making Heart Attack History©
  • 7.
  • 8.
  • 9.
  • 10. Sheldon Adelson SHAPE Trial Proposal The Association for Eradication of Heart Attack (www.AEHA.org)The Association for Eradication of Heart Attack (www.AEHA.org) Quantum Leap in Preventive Cardiology
  • 11.
  • 12.
  • 13. Goal Compare SHAPE v.s. Status Quo in Reducing Cardiovascular Mortality and Morbidity The Sheldon Adelson SHAPE Trial
  • 14. Study Design Randomized trial with three arms: - SHAPE Guidelines - NCEP Guidelines - Traditional practice (stress testing) Screen and treat asymptomatic at-risk population (men 45-75y women 55-75y) according to each of the above. The Sheldon Adelson SHAPE Trial
  • 15. Study Design Sample size: 15,000 total 5,000 in each arm matched with age, sex, and ethnicity Follow up: 10 years The Sheldon Adelson SHAPE Trial
  • 16. • 15,000 persons followed for 10 years (6 clinic visits at $250 per visit, plus $500 per patient for enrollment) $30M • Operations for 20 study sites at $200K/year = $40M The Sheldon Adelson SHAPE Trial
  • 17. Goals A) Establish AEHA (Association for the Eradication of Heart Attack) as the global leader of a revolutionary movement in the field of cardiology and public health (beyond AHA and ACC) to lead the way for eradicating heart attack. B) Establish AVPRI (Adelson Vulnerable Patient Research Institute) as the leading R&D institution in developing new technologies and methods for screening, detection, and treatment of the vulnerable patient.
  • 18. Outline of the Projects A) AEHA: • Public education and fundraising (SHAPE, SHAPE-a- thon, and the Vaccine Initiative) • Professional: ACPC (American College of Preventive Cardiology), JPC (Journal of Preventive Cardiology), National Guidelines and Task Forces (SHAPE, PolyPill, Vaccine), B) AVPRI: • Biomarker (serum markers and non-imaging monitoring tools) • Imaging (non-contrast CT, VP Score, contrast enhanced plaque characterization, and Molecular Imaging of ) • Immune modulation therapy (for rapid plaque stabilization)
  • 19. Budget • The proposal is based on a 50 million dollar budget over 10 years (Phase I to Phase V). • Sources of funds: The Adelson Foundation and matching funds from NIH, NSF, CV industry, and other donors including public fundraising. • The Adelson Foundation will be named as the first principal donor of AEHA, and the sole name on AVPRI.
  • 20. Budget • The first 2 years --Phase I: including discovery, organization, and one year funded research for 3 institutions in collaboration with AVPRI-- is budgeted at $5 millions. • During the Phase I, necessary data for submitting NIH grants and obtaining matching funds • Given successful meeting of the Phase I milestones at 18 months, a detailed budget for Phase II-V will be submitted.
  • 21. Budget for Phase I • AVPRI 3 millions ? – New CCS score – Molecular Imaging? • AEHA 2 millions ? – SHAPE and Vaccine Task Force, Symposia, Public Relations, Fundraising and SHAPE-a- thon – ACPC, and JPC Journal?
  • 22. Budget for Phase I • AVPRI 3 millions ? – New CCS score – Molecular Imaging?
  • 23. Setting A) AEHA and AVPRI completely non-profit and educational. Both will be tied from organizational stand point (board of directors etc). Fundraising foundation arms will be the major organs of the organization and donations will be the major source of income beside conventions and educational products. Depending on the success in fundraising both may offer grant opportunities and in case of new inventions and discoveries the organization will license out technologies. In the far future depending on the level of success it may open a venture arm to fund spin off start ups that are totally focused on the mission of eradicating heart attacks. Existing (but far less than perfect) models for AEHA are ACS, AHA, and ADA, and for ACPC are ACC and RSNA
  • 24. Setting B) AVPRI can be a for-profit research institute (if Adelson wants his money back upon the success of the institute) or a non-profit research institute. To succeed quickly given the extremely competitive environment, small budget, and so many other reasons, it needs to be (or at least start) more like a virtual campus, building projects predominantly based on collaborative multi- center projects through various master agreements for affiliation. It can act like a vehicle (an off shore company) but strong management and great ideas. It can license in technologies to complete its package and it will be heavily involved in spinning off technologies and incubating startups.
  • 25.
  • 26. Heart attack is NOT the world’s number one problem, extreme poverty is. The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 27. “50,000 per day die of infectious diseases which could almost all be cured or prevented at a cost which is sometimes no more than $1 per person” World Health Organization The AEHA 2005 VP SummitThe AEHA 2005 VP Summit Extreme Poverty Is a Shame to the World
  • 28. Much Kudus to Bono and the One Campaign Extreme Poverty Is a Shame to the World The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 29. After extreme poverty and associated infectious diseases, eradication of heart attack can be the most rewarding opportunity in the 21st century for saving productive life years worldwide. The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 30. How the World Dies Today? YLLs: Yearsof LifeLost Atherosclerotic Diseases The AEHA 2005 VP SummitThe AEHA 2005 VP SummitWorld Health Organization
  • 31. Worldwide Causes of Death Source: WHO The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 32. > 15 Million Heart Attacks Each Year Source: World Heart Federation The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 33. 0 5 10 15 20 25 30 1990 2020 MillionsofDeaths fromCardiovascularCauses Western countries Non-Western (developing) countries 5 million DEATHS FROM CARDIOVASCULAR CAUSES WORLDWIDE KS Reddy. NEJM 2004; 350:2438 9 million 19 million 6 million Over 2/3 of the global burden of heart attack and stroke is on poor countries. ~15m today >25m tomorrow The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 34. The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 35. More thanMore than half causedhalf caused by a suddenby a sudden heart attackheart attack inin healthy-healthy- lookinglooking populationpopulation The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 36.
  • 37. The AEHA 2005 VP SummitThe AEHA 2005 VP Summit Epidemic of Heart Failure
  • 38. Global Epidemic of Diabetes The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 39. Epidemic of Obesity & Diabetes in the U.S. 1990/19911990/1991 20002000 ejt 0901–120 Mokdad et al., JAMAMokdad et al., JAMA 286:1195–1200, 2001286:1195–1200, 2001 No DataNo Data < 4%< 4% 4%-6%4%-6% > 6%> 6% No DataNo Data < 10%< 10% 10%-14%10%-14% 15%-19%15%-19% ≥≥ 20%20% ObesityObesity DiabetesDiabetes The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 40. Global Atherosclerosis; A Bigger Threat than Global Warming! The AEHA 2005 VP SummitThe AEHA 2005 VP Summit
  • 41. •Heart attack is not equal to heart disease, and is not equal to atherosclerosis either. It is the attack part of coronary heart disease that is most devastating, and the first focal point of the AEHA movement. Heart attack is the tip of atherosclerosis problem. The AEHA 2005 VP SummitThe AEHA 2005 VP Summit Prevent Attack!
  • 42.
  • 43. Atherosclerosis Test Negative Positive No Risk Factors + Risk Factors Step 1 Test for Presence of the Disease Step 2 Stratify based on the Severity of the Disease and Presence of Risk Factors Step 3 Treat based on the Level of Risk Lower Risk Moderate Risk Moderately High Risk High Risk Very High Risk Apparently Healthy At-Risk Population The 1st S.H.A.P.E. Guideline Towards the National Screening for Heart Attack Prevention and Education (SHAPE) Program Conceptual Flow Chart <75th Percentile 75th-90th Percentile ≥90th Percentile
  • 44.
  • 45. Atherosclerosis Test Very Low Risk 3 Negative Test • CCS =0 • CIMT<50th percentile Lower Risk Moderate Risk Positive Test • CCS ≥1 • CIMT ≥50th percentile or Carotid Plaque Moderately High Risk High Risk Very High Risk No Risk Factors5 + Risk Factors • CCS <100 & <75th% • CIMT <1mm & <75th% & No Carotid Plaque • Coronary Calcium Score (CCS) or • Carotid IMT (CIMT) & Carotid Plaque4 • CCS 100-399 or >75th% • CIMT ≥1mm or >75th% or <50% Stenotic Plaque • CCS >100 & >90th% or CCS ≥400 • ≥50% Stenotic Plaque6 IndividualizedIndividualizedIndividualized5-10 years5-10 yearsRe-test Interval <70 mg/dl<100 mg/dl <70 Optional <130 mg/dl <100 Optional <130 mg/dl<160 mg/dlLDL Target All >75y receive unconditional treatment2 Apparently Healthy Population Men>45y Women>55y1 ExitExit Myocardial IschemiaTest NoAngiography Follow Existing Guidelines Yes The 1st S.H.A.P.E. Guideline Towards the National Screening for Heart Attack Prevention and Education (SHAPE) Program Step 1 Step 2 Step 3 Optional CRP>4mg ABI<0.9
  • 46.
  • 47. Heart Attack Eradication History Makers Faculty of the Past 9 VP Symposia and the SHAPE Task Force
  • 48. Lets Hope the World Will Do First Thing First!
  • 49. SHAPE